Plan B Decision Expected In Coming Weeks, Barr CEO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Downey says Rx sales of approximately $20 mil. have restricted availability of the emergency contraceptive at pharmacies across the country.
You may also be interested in...
Plan B Headed For Behind-The-Counter Sale
FDA is understood to have decided to approve the emergency contraceptive as a new, third class of product, which would restrict access but not require a prescription.
NDAC Approach To OTC Switches Highlighted At Corticosteroid Meeting
Panel review provides examples of different attitudes toward switches between OTC experts, other category-specific prescribers.